Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 13, 2017 - Issue
Submit an article Journal homepage
88
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder

Manish K Jha1 Center for Depression Research and Clinical Care, University of Texas Southwestern Medical Center, Dallas
,
Raymond B Teer2 University of Texas, Austin
,
Abu Minhajuddin3 Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA
,
Tracy L Greer1 Center for Depression Research and Clinical Care, University of Texas Southwestern Medical Center, Dallas
,
A John Rush4 Duke-NUS, Singapore, Singapore
&
Madhukar H Trivedi1 Center for Depression Research and Clinical Care, University of Texas Southwestern Medical Center, DallasCorrespondence[email protected]
Pages 803-813 | Published online: 15 Mar 2017

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Vicki Soogrim, Valerie L Ruberto, James Murrough & Manish Kumar Jha. (2021) Spotlight on Pimavanserin Tartrate and Its Therapeutic Potential in the Treatment of Major Depressive Disorder: The Evidence to Date. Drug Design, Development and Therapy 15, pages 151-157.
Read now

Articles from other publishers (15)

Collin Vas, Ayush Jain, Mili Trivedi, Manish Kumar Jha & Sanjay J. Mathew. (2023) Pharmacotherapy for Treatment-Resistant Depression. Psychiatric Clinics of North America 46:2, pages 261-275.
Crossref
Kimberlyn Maravet Baig-Ward, Manish Kumar Jha & Madhukar H. Trivedi. (2023) The Individual and Societal Burden of Treatment-Resistant Depression. Psychiatric Clinics of North America 46:2, pages 211-226.
Crossref
Rudy Lozano Carreon, Ana Maria Rivas-Grajales, Nicholas Murphy, Sanjay J. Mathew & Manish K. Jha. 2023. Drug Development in Psychiatry. Drug Development in Psychiatry 287 297 .
Troy K. Chow, Christopher R. Bowie, Michael Morton, Aleksandra Lalovic, Shane J. McInerney & Sakina J. Rizvi. (2022) Contributors of Functional Impairment in Major Depressive Disorder: a Biopsychosocial Approach. Current Behavioral Neuroscience Reports 9:2, pages 59-72.
Crossref
Abu Minhajuddin, Manish K. Jha, Cherise Chin Fatt & Madhukar H. Trivedi. (2020) Psychometric Properties of the Concise Associated Symptom Tracking Scale and Validation of Clinical Utility in the EMBARC Study. Psychiatric Research and Clinical Practice 2:1, pages 10-18.
Crossref
A. John RushMichael E. Thase. (2020) Improving Depression Outcome by Patient-Centered Medical Management. FOCUS 18:2, pages 244-254.
Crossref
Yuncheng Zhu, Zhiguo Wu, Oliver Sie, Yiyun Cai, Jia Huang, Hongmei Liu, Yamin Yao, Zhiang Niu, Xiaohui Wu, Yifan Shi, Chen Zhang, Tiebang Liu, Han Rong, Haichen Yang, Daihui Peng & Yiru Fang. (2020) Causes of drug discontinuation in patients with major depressive disorder in China. Progress in Neuro-Psychopharmacology and Biological Psychiatry 96, pages 109755.
Crossref
Tracy L. Greer & Jeethu K. Joseph. 2020. Major Depressive Disorder. Major Depressive Disorder 131 146 .
Timothy A. Allen, Raymond W. Lam, Roumen Milev, Sakina J. Rizvi, Benicio N. Frey, Glenda M. MacQueen, Daniel J. Müller, Rudolf Uher, Sidney H. Kennedy & Lena C. Quilty. (2018) Early change in reward and punishment sensitivity as a predictor of response to antidepressant treatment for major depressive disorder: a CAN-BIND-1 report. Psychological Medicine 49:10, pages 1629-1638.
Crossref
Manish K. JhaAbu MinhajuddinCharles SouthA. John RushMadhukar H. Trivedi. (2019) Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity. American Journal of Psychiatry 176:5, pages 358-366.
Crossref
Manish K Jha, Charles South, Jay Trivedi, Abu Minhajuddin, A John RushMadhukar H Trivedi. (2019) Prediction of Acute-Phase Treatment Outcomes by Adding a Single-Item Measure of Activity Impairment to Symptom Measurement: Development and Validation of an Interactive Calculator from the STAR*D and CO-MED Trials. International Journal of Neuropsychopharmacology 22:5, pages 339-348.
Crossref
Manish K Jha, Abu Minhajuddin, Charles South, A John Rush & Madhukar H Trivedi. (2018) Worsening Anxiety, Irritability, Insomnia, or Panic Predicts Poorer Antidepressant Treatment Outcomes: Clinical Utility and Validation of the Concise Associated Symptom Tracking (CAST) Scale. International Journal of Neuropsychopharmacology 21:4, pages 325-332.
Crossref
Manish Jha & Madhukar Trivedi. (2018) Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation. International Journal of Molecular Sciences 19:1, pages 233.
Crossref
Ronald C. Kessler. (2018) The potential of predictive analytics to provide clinical decision support in depression treatment planning. Current Opinion in Psychiatry 31:1, pages 32-39.
Crossref
A. John Rush & Shailesh (Bobby) Jain. 2019. Antidepressants. Antidepressants 51 99 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.